Indians that aged in the range of 20-45 years old are usually worried about their lifstyle diseases and about 45% of young people are vulnerable to non-communicable diseases like diabetes, hypertension and depression.
The is a rise in the number of Africans suffering from lifestyle illnesses, one of which is cancer. Unhealthy habits contribute to the development of the disease. Poor hospital services also add to the trouble of patients.
International scientists and physicians met in Texas for the San Antonio Breast Cancer Symposium, a collaborative effort among cancer experts to present the latest researches on breast cancer.
Numerous studies have revealed the dangers of smoking e-cigarettes, with some reports citing that the effects of e-ciagrettes are of the same magnitude as that of traditional cigarettes. While some orgaizations encourage smokers to switch from tobacco to e-cigarettes, there are also many who call for the regulation of the use of e-cigarettes because of the harm it poses to people's health.
Self.made billionaire Sean Parker continues his vision on advancing medical researches. His Parker Institute for Cancer Immunotherapy collaborated with the Cancer Research Institute in an effort to use algorith in uncovering neoantigens.
Cancer research Father, Umberto Veronesi dies at 90.
The Oak Ridge National Laboratory (ORNL), home to several of the world’s top supercomputers, strengthens the battle against cancer through conducting several experiments on how deep learning can contribute for the development of cancer research.
Pierce Brosnan said that he is unaware that the product has harmful ingredients. They only told him that the product is just a breath freshener and tooth whitener.
Celator Pharmaceuticals shares jumped more than 400% in Tuesday trading. Meanwhile, hedge fund manager Steve Cohen unvelied his 8.3% shares of the company.
The Series A round was announced on Wednesday. The company has also licensed the rights for multiple immuno-oncology programs from Stanford University.
Intel Health executive Eric Dishman has to fight his Kidney Cancer for 23 years before it was treated. Now, Intel launched a network that would make cancer treatment plans in just 1 day by 2020.
Geron Corp licensed its cancer compound, the last in its pipeline, to a unit of Johnson & Johnson for up to $935 million, sending its shares up as much as 33 percent in extended trading.
How long patients survive after surgery to remove lung cancer may depend on factors like insurance, income and education, according to a new study.
AstraZeneca's cancer drug pipeline, already on a roll following promising clinical trial results, could get a further boost next week from a European green light for an experimental medicine against ovarian cancer.
The U.S. Food and Drug Administration said on Friday it has approved Japanese pharmaceutical company Eisai's drug Akynzeo to treat nausea and vomiting in patients undergoing chemotherapy for cancer.
Subscribe to VCpost newsletter
- Lance Armstrong's Next Ventures Raises $24.5 Million Of Expected $75 Million Fundraise
- Implied SPDR S&P MIDCAP 400 ETF Analyst Target Price: $389
- What This Centi-Billionaire Fashion Magnate Can Teach You About Investing
- ADP vs. Paychex: Comparing Key Metrics For The Two Largest Payroll Processing Companies
- After Energy Sector Earnings Plunge In Q1, Hopes Rise For Improved Q2 Performance
- Are Strong Jobs Really Bad For Stocks?
- 4 Price Charts You Should See: Bank Stocks Are Showing Relative Weakness
- Citigroup's $21.5-Billion Capital Return Plan For 2019 Is Slightly Lower Than Its 2018 Plan